Table 1.
Patient Demographics Based on Fibrosis Staging.
| METAVIR Stage | ||
| F0-F1 | F3-F4 | |
| Age (y) | 43.8 ± 9.75 | 48.1 ± 4.18 |
| Sex (M/F) | 21/2 | 19/2 |
| Race | ||
| White | 20 | 19 |
| Hispanic | 2 | 2 |
| Asian | 1 | 0 |
| HCV genotype | ||
| 1 | 18 | 14 |
| 2 | 3 | 2 |
| 3 | 2 | 5 |
| Duration of infection (y) | 22.1 ± 6.03 | 22.9 ± 6.68 |
| ALT (IU/mL) | 101.7 ± 61.64a | 129.8 ± 69.19b |
| METAVIR Activity | 1 (0–3)c | 2 (0–3)d |
| HCV RNA (log10 copies/mL) | 6.53 ± 0.39 | 6.43 ± 0.43 |
Results shown as mean ± standard deviation, number, or median (range); ALT, alanine aminotransferase; HCV, hepatitis C virus; METAVIR Activity, histological score of necroinflammation based on interface, lobular, and portal inflammation. a vs. b, p = 0.16; c vs. d, p = 0.07